NeuroVive Pharmaceutical AB Bennfentes tulajdonlás
Mi az NeuroVive Pharmaceutical AB Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az NeuroVive Pharmaceutical AB - 17.55%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Miscellaneous szektor a LSE-on cégekben a NeuroVive Pharmaceutical AB -hoz képest
Mit csinál NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
bennfentes tulajdonlás -hoz hasonló cégek NeuroVive Pharmaceutical AB
- Meteorite Capital nak Bennfentes tulajdonlás 17.54% van
- Distribution Finance Capital plc nak Bennfentes tulajdonlás 17.54% van
- Electro Optic Systems nak Bennfentes tulajdonlás 17.55% van
- Kuya Silver nak Bennfentes tulajdonlás 17.55% van
- Medgold Resources nak Bennfentes tulajdonlás 17.55% van
- HMN nak Bennfentes tulajdonlás 17.55% van
- NeuroVive Pharmaceutical AB nak Bennfentes tulajdonlás 17.55% van
- Ponce Inc nak Bennfentes tulajdonlás 17.56% van
- Valneva SE nak Bennfentes tulajdonlás 17.57% van
- Sichuan Expressway nak Bennfentes tulajdonlás 17.57% van
- Valneva SE nak Bennfentes tulajdonlás 17.57% van
- China Merchants Bank Co nak Bennfentes tulajdonlás 17.57% van
- Synaptogenix Inc nak Bennfentes tulajdonlás 17.57% van